Vermont drops all COVID-19 restrictions after reaching 80% vaccination rate

Vermont is ahead of the vaccination curve compared to the rest of the United States. The Green Mountain State recently reached a new milestone, with 80% of its eligible residents having received at least one vaccine dose to protect against COVID-19.

In reaction, the state has dropped all COVID-19 restrictions. Vermont’s state of emergency, which ends June 15, will not be renewed, Governor Phil Scott announced June 14. 

“Today, I’m very proud to announce that Vermont has now become the first state in the nation to vaccinate 80% of its 12 and over population,” Scott said.

The state exceeded President Biden’s goal of reaching a 70% vaccination rate among the U.S. adult population by the 4th of July holiday. Vermont reported 81.8% of its eligible 18+ population had received at least one vaccine dose. Just over 43% of the U.S. population at large is vaccinated, according to the Centers for Disease Control and Prevention. The percentage of adults with at least one dose is 64.5%, CDC data reveals

“We said from the very start, and in the face of criticism, that our vaccine strategy would prove to be the most effective in the nation,” Scott said. “That in order to protect the most vulnerable, a simple-to-understand and easy-to-implement age-banded strategy would deliver the best results. Again, not only do we lead the United States, but Vermont is now a global leader in vaccinations to defeat COVID-19.”

All of Vermont’s COVID-19 restrictions are rescinded, unless there is a federal restriction, such as federal transportation and travel requirements. The change in policy comes as the number of deaths and cases in the U.S. from COVID-19 have continued to fall.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.